Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT01619085 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01619085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01619085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Extension Trial of the Long Term Safety of Oral BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Lead sponsor
Boehringer Ingelheim
Phase
Phase 3
Overall status
Completed
Start date
June 6, 2012
Completion date
February 1, 2021
Enrollment
752 (actual)
Sites
173

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis